Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT04946370 · RECRUITING
Trial details
- NCT number
- NCT04946370
- Sponsor
- Weill Medical College of Cornell University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-12
- Primary completion
- 2027-10-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.